LETTERS the exact tissue type of each sample, only that tonsils, adenoids, or both combined could be present, the 5.5% rate we found was about one third the rate found in tonsil lymphocytes and about one tenth the rate found in adenoid lymphocytes. A seasonal effect may contribute to the large discrepancies found in HBoV prevalences. Apparently, viruses can persist in tonsillar tissue well after the symptomatic phase of illness. In children with no signs of acute respiratory infection, Drago et al. (7) reported that 45.5% of samples contained viral nucleic acid. Depending on the duration of persistence, asymptomatic children, sampled shortly after the season of the virus in question, would be more likely to have detectable virus in their tonsillar tissue. The Longtin et al. study samples were collected from December through April; our study samples were collected from June through September. If HBoV is seasonal, as has been suggested (3), it may have been circulating in the target population before samples were taken and persisted only in tonsillar tissues. Thus, if tonsillar tissue from asymptomatic children was obtained within the persistence period after the HBoV season, samples would be HBoV positive; those obtained shortly after the persistence period would have a much lower rate. Differences in patient age in the 3 studies may also have contributed to the different rates observed. The Longtin et al. group was substantially younger (median age 23 months) than the Lu et al. group (median age 5 years) or our group (median age 5.9 years). Preliminary seroepidemiology reports indicate the presence of HBoV antibodies in >50% of children 2–3 years of age (8,9). The detection of HBoV in the tonsillar tissues we tested showed a higher rate of infection than would be expected in an asymptomatic population. However, the rate was far lower than that previously reported for tonsillar tissues (1,4). 1150 Nathalie Clément,1 Gino Battaglioli, Ryan L. Jensen,2 Bruce C. Schnepp,2 Philip R. Johnson,2 Kirsten St. George, and R. Michael Linden3 Author affiliations: Mount Sinai School of Medicine, New York, New York, USA (N. Clément, R.M. Linden); Wadsworth Center, Albany, New York, USA (G. Battaglioli, K. St. George); and Nationwide Children’s Hospital, Columbus, Ohio, USA (R.L. Jensen, B.C. Schnepp, P.R. Johnson) DOI: 10.3201/eid1507.090102 References 1. 2. 3. 4. 5. 6. Longtin J, Bastien M, Gilca R, Leblanc E, de Serres G, Bergeron MG, et al. Human bocavirus infections in hospitalized children and adults. Emerg Infect Dis. 2008;14:217–21. DOI: 10.3201/ eid1402.070851 Fry AM, Lu X, Chittaganpitch M, Peret T, Fischer J, Dowell SF, et al. Human bocavirus: a novel parvovirus epidemiologically associated with pneumonia requiring hospitalization in Thailand. J Infect Dis. 2007;195:1038–45. DOI: 10.1086/512163 Kesebir D, Vazquez M, Weibel C, Shapiro ED, Ferguson D, Landry ML, et al. Human bocavirus infection in young children in the United States: molecular epidemiological profile and clinical characteristics of a newly emerging respiratory virus. J Infect Dis. 2006;194:1276–82. DOI: 10.1086/508213 Lu X, Gooding LR, Erdman DD. Human bocavirus in tonsillar lymphocytes. Emerg Infect Dis. 2008;14:1332–4. DOI: 10.3201/ eid1408.080300 PMID: 18680679 Chen CL, Jensen RL, Schnepp BC, Connell MJ, Shell R, Sferra TJ, et al. Molecular characterization of adenoassociated viruses infecting children. J Virol. 2005;79:14781–92. DOI: 10.1128/ JVI.79.23.14781-14792.2005 Allander T, Tammi MT, Eriksson M, Bjerkner A, Tiveljung-Lindell A, Andersson B. Cloning of a human parvovirus by molecular screening of respiratory Current affiliation: University of Florida, Gainesville, Florida, USA. 1 Current affiliation: Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. 2 Current affiliation: King’s College, London, UK. 3 tract samples. Proc Natl Acad Sci U S A. 2005;102:12891–6. DOI: 10.1073/pnas. 0504666102 7. Drago L, Esposito S, De Vecchi E, Marchisio P, Blasi F, Baggi E, et al. Detection of respiratory viruses and atypical bacteria in children’s tonsils and adenoids. J Clin Microbiol. 2008;46:369–70. DOI: 10.1128/JCM.01819-07 8. Kahn JS, Kesebir D, Cotmore SF, D’Abramo A, Cosby C, Weibel C, et al. Seroepidemiology of human bocavirus defined using recombinant virus-like particles. J Infect Dis. 2008;198:41–50. DOI: 10.1086/588674 9. Lindner J, Karalar L, Zehentmeier S, Plentz A, Pfister H, Struff W, et al. Humoral immune response against human bocavirus VP2 virus-like particles. Viral Immunol. 2008;21:443–9. DOI: 10.1089/ vim.2008.0045 Address for correspondence: Gino Battaglioli, Laboratory of Viral Diseases, Wadsworth Center, New York State Department of Health, Empire State Plaza, PO Box 509, Albany, NY 12201, USA; email: battagli@wadsworth.org Bartonella rochalimae and Other Bartonella spp. in Fleas, Chile To the Editor: Fleas are involved in the natural cycle of different Bartonella spp. Among the 20 currently recognized Bartonella spp., 13 species or subspecies have been implicated in human disease. Recently, B. rochalimae was identified in a patient who had received numerous insect bites and subsequently had bacteremia, fever, and splenomegaly after visiting Peru (1). A recent study in Taiwan suggested that rodents could be a reservoir for B. rochalimae (2), but the vector or other mechanism of infection remains unknown. We amplified B. rochalimae, B. clarridgeiae, and B. henselae from fleas (Pulex irritans and Ctenocephalides felis) collected in Chile and dis- Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 7, July 2009 LETTERS cuss the role of these fleas as possible vectors of infection. From 2005 through 2008, we collected 82 fleas from cats and dogs in pounds in Chile: 34 P. irritans, 37 C. felis, and 11 C. canis. Fleas were kept in 70% ethanol and sent to the Special Pathogens Laboratory of the Área de Enfermedades Infecciosas of the Hospital San Pedro, La Rioja, Spain, to be examined for Bartonella spp. Fleas were then rinsed in distilled water and dried on sterile filter paper under a laminar-flow hood. Each flea was crushed with a sterile pestle, and DNA was extracted by lysis with 0.7 M ammonium hydroxide. PCR was used to detect Bartonella DNA (according to the defining criteria for Bartonella spp.); primers targeted the RNA polymerase β-subunit–encoding gene (rpoB) and the citrate synthase gene (gltA) (3–5). PCR primers for a fragment of the 16/23S rRNA intergenic region and the heat-shock protein-encoding gene (groEL) were also used (6,7). Positive controls (B. henselae strain Marseille, kindly supplied by Unité des Rickettsies, Faculté de Médecine, Université de la Méditerranée, Marseille, France) and negative controls (sterile water instead of template DNA) were used. PCR products were purified, and both strands of each amplicon were subjected to sequence analysis. Nucleotide sequence homologies were searched by using BLAST (www.ncbi.nlm.nih. gov/blast/Blast.cgi). When rpoB primers were used, Bartonella spp. were found in 4 C. felis (4.8%) fleas from cats and in 4 P. irritans (4.8%) fleas from dogs. The same 8 samples were positive when primers for gltA gene and 16/23S rRNA intergenic region were used. Unfortunately, none of the 82 specimens were positive when PCR primers targeting the groEL gene were used. In all experiments, negative controls remained negative. Sequencing of the 825-bp rpoB fragments from the 4 C. felis fleas indicated that they were most closely aligned with the gene sequences of B. clarridgeiae (n = 2, >99% similarity) and B. henselae (n = 2, 100% similarity). Using gltA (380 bp), we found 100% similarity with B. clarridgeiae and B. henselae. Accordingly, the 16/23S rRNA amplicons from these specimens exhibited 100% similarity with the corresponding sequences of B. clarridgeiae (154 bp) and B. henselae (172 bp). Amplicons for the rpoB fragment gene obtained from 4 P. irritans fleas showed highest similarity (97.2%–99.5%) with rpoB of B. rochalimae. Three were identical, and we deposited the consensus sequence in GenBank in 2006 under the name “uncultured Bartonella sp.” and accession no. DQ858956. The sequence differed from those described for all known Bartonella spp. and phylogenetically was most closely related to B. clarridgeiae (8). The sequence of the protein encoded by rpoB in these 3 specimens (protein_id ABH09235) had 3 aa changes (121I→V, 233K→I, and 274N→E) with respect to the deduced sequence of the RpoB protein for B. rochalimae. The importance of these changes remains unknown. The remaining nucleotide sequence was recently submitted to GenBank under accession no. FJ147196, designated B. rochalimae because isolation of this new Bartonella spp. was reported in 2007 (1). These 4 specimens also yielded positive PCR products for gltA (380 bp) and 16/23S rRNA (≈175 bp). Subsequent nucleotide sequence analysis showed 100% homology with the corresponding partial nucleotide sequences from B. rochalimae. In 2002, Parola et al. (9) amplified Bartonella DNA by using PCR with Pulex spp. fleas collected from persons in Peru and suggested the existence of a new Bartonella sp. The nucleotide sequence of the 16S-23S ribosomal RNA intergenic spacer obtained from 1 genotype (clone F17688) was nearly identical to the corresponding sequence of B. rochalimae. This finding suggests that Pulex spp. fleas could be vectors. Cat scratch disease has been reported in Chile, and B. henselae has been found in cats in Chile (10). Thus, our finding of B. henselae and B. clarridgeiae in C. felis fleas from Chile confirms the risk for exposure of humans in contact with cat fleas. Furthermore, our finding of B. rochalimae in P. irritans fleas from dogs in Chile supports the possibility that P. irritans fleas could be vectors for B. rochalimae. These findings are of public health importance because they identify possible vectors of these human pathogens. Acknowledgments We are grateful to Lourdes Romero and Josune García for their contribution to this work. Laura Pérez-Martínez, José M. Venzal, Daniel González-Acuña, Aránzazu Portillo, José R. Blanco, and José A. Oteo Author affiliations: Hospital San Pedro-Centro de Investigación Biomédica de La Rioja, Logroño, Spain (L. Pérez-Martínez, A. Portillo, J.R. Blanco, J.A. Oteo); Universidad de la República, Montevideo, Uruguay (J.M. Venzal); and Universidad de Concepción, Chillán, Chile (D. González-Acuña) DOI: 10.3201/eid1507.081570 References 1. Eremeeva ME, Gerns HL, Lydy SL, Goo JS, Ryan ET, Mathew SS, et al. Bacteremia, fever, and splenomegaly caused by a newly recognized Bartonella species. N Engl J Med. 2007;356:2381–7. DOI: 10.1056/NEJMoa065987 2. Lin JW, Chen CY, Cehn WC, Chomel BB, Chang CC. Isolation of Bartonella species from rodents in Taiwan including a strain closely related to ‘Bartonella rochalimae’ from Rattus novergicus. J Med Microbiol. 2008;57:1496–501. DOI: 10.1099/ jmm.0.2008/004671-0 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 7, July 2009 1151 LETTERS 3. 4. 5. 1152 Renesto P, Gouvernet J, Drancourt M, Roux V, Raoult D. Use of rpoB gene analysis for detection and identification of Bartonella species. J Clin Microbiol. 2001;39:430–7. DOI: 10.1128/ JCM.39.2.430-437.2001 Norman AF, Regnery R, Jameson P, Greene C, Krause DC. Differentiation of Bartonella-like isolates at the species level by PCR-restriction fragment length polymorphism in the citrate synthase gene. J Clin Microbiol. 1995;33:1797–803. La Scola B, Zeaiter Z, Khamis A, Raoult D. Gene-sequence–based criteria for species definition in bacteriology: the Bartonella paradigm. Trends Microbiol. 2003;11:318–21. DOI: 10.1016/S0966842X(03)00143-4 6. Jensen WA, Fall M, Rooney J, Kordick DL, Breitschwerdt EB. Rapid identification and differentiation of Bartonella species using a single-step PCR assay. J Clin Microbiol. 2000;38:1717–22. 7. Sanogo YO, Zeaiter Z, Caruso G, Merola F, Shpynov S, Brouqui P, et al. Bartonella henselae in Ixodes ricinus ticks (Acari: Ixodida) removed from humans, Belluno Province, Italy. Emerg Infect Dis. 2003;9:329–32. 8. González-Acuña D, Pérez-Martínez L, Venzal JM, Portillo A, Santibáñez S, Ibarra V, et al. Detection of Bartonella sp. in Pulex irritans from Chile. In: Abstracts of the 20th Meeting of the American Society for Rickettsiology and the 5th International Conference on Bartonella as Emerging Pathogens; 2006 Sep 2–7; Pacific Grove, California, USA. Abstract 154. 9. Parola P, Shpynov S, Montoya M, Lopez M, Houpikian P, Zeaiter Z, et al. First molecular evidence of new Bartonella spp. in fleas and a tick from Peru. Am J Trop Med Hyg. 2002;67:135–6. 10. Ferrés M, Abarca K, Godoy P, García P, Palavecino E, Méndez G, et al. Presence of Bartonella henselae in cats: natural reservoir quantification and human exposition risk of this zoonoses in Chile. Rev Med Chil. 2005;133:1465–71. Address for correspondence: José A. Oteo, Área de Enfermedades Infecciosas, Hospital San Pedro, C/Piqueras 98-7ª NE, 26006 – Logroño (La Rioja), Spain; email: jaoteo@riojasalud.es Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 7, July 2009